Anish Suri - Oct 3, 2021 Form 4 Insider Report for Cue Biopharma, Inc. (CUE)

Signature
/s/ Anish Suri by Colin Sandercock, attorney-in-fact
Stock symbol
CUE
Transactions as of
Oct 3, 2021
Transactions value $
-$183,318
Form type
4
Date filed
10/8/2021, 04:00 PM
Previous filing
Sep 27, 2021
Next filing
Nov 15, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CUE Common Stock Options Exercise +33.3K +44.54% 108K Oct 3, 2021 Direct F1
transaction CUE Common Stock Tax liability -$183K -14.1K -13.07% $12.97 94K Oct 6, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CUE Restricted Stock Units Options Exercise $0 -33.3K -100% $0.00* 0 Oct 3, 2021 Common Stock 33.3K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock received upon vesting of a restricted stock unit award.
F2 Each restricted stock unit award represents a contingent right to receive one share of common stock.
F3 On October 3, 2019, the reporting person was granted 100,000 restricted stock units, scheduled to vest in three equal annual installments beginning on October 3, 2019.